Atlas Trials

A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris

Clinical trial NCT02431052 · COMPLETED

Trial details

NCT number
NCT02431052
Sponsor
Dermira, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2015-04-01
Primary completion
2016-04-01
Enrollment
420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.